Nanotoxicity and the importance of being earnest
Pages 1661-1662Thomas Vorup-Jensen, Dan Peer
Advancing risk assessment of engineered nanomaterials: Application of computational approaches
Pages 1663-1693Agnieszka Gajewicz, Bakhtiyor Rasulev, Tandabany C. Dinadayalane, Piotr Urbaszek, Tomasz Puzyn, Danuta Leszczynska, Jerzy Leszczynski
Polycation-based nanoparticle delivery of RNAi therapeutics: Adverse effects and solutions
Pages 1717-1729Borja Ballarín-González, Kenneth Alan Howard
Safety profile of RNAi nanomedicines
Pages 1730-1737Scott A. Barros, Jared A. Gollob
Risks and untoward toxicities of antibody-based immunoconjugates
Pages 1782-1799Dana Litvak-Greenfeld, Itai Benhar
No comments:
Post a Comment